Marshall Glesby

Marshall Glesby, M.D., Ph.D. is a Professor of Medicine and Population Health Sciences at Weill Cornell Medical College, serving as Associate Chief of the Division of Infectious Diseases and Director of the Cornell HIV Clinical Trials Unit. He provides longitudinal care to HIV-infected patients at the Center for Special Studies and contributes to clinical trials through the NIH-sponsored AIDS Clinical Trials Group (ACTG).

• Education:
  • Ph.D. in Clinical Investigation, Johns Hopkins School of Hygiene and Public Health (1997)
  • M.D., Johns Hopkins University School of Medicine (1989)
  • B.Sc., McGill University (1985)

Research Interests encompass metabolic complications of HIV therapy, aging in HIV patients, tropical co-infections (leishmaniasis, HTLV-I), and cardiometabolic interactions in HIV. His work bridges clinical trials, immunological biomarker discovery, and public health implications of HIV comorbidities.

Recent Publications highlight HIV-1 remission post-haplo-cord transplant, mpox severity scoring systems, and mitochondrial DNA as a biomarker for geriatric syndromes. These studies span disciplines including Infectious Diseases, Neuroscience, and Public Health.

• Scientific Awards:
  • John E. Carey Young Investigator Award (2003)
  • Excellence in Training Award (2010)

Leadership Roles include directing the Weill Cornell AETC site and serving on the FDA's Antiviral Drugs Advisory Committee. He co-directs the Clinical Trials Design and Analysis course in the Masters in Clinical Investigation program.